CASE HUB (Appeals lodged at the General Court in Cases T- 460/13 (Sun Pharma), T- 467/13 (Arrow), T- 469/13 (Generics UK), T- 470/13 (Merck), T- 471/13 (Xellia) and T- 472/13 (Lundbeck)–see Cases T- 472/13 Lundbeck v Commission, et al (Pay-for-delay) [Archived]) ARCHIVED–this archived case hub reflects the position at the date of the decision of 19 June 2013; it is no longer maintained. See further, timeline, commentary and related cases. Case facts Outline European Commission Article 101 TFEU investigation into Lundbeck and others (Citalopram) (case number COMP/39.226). Latest development On 19 June 2013, the Commission issued its enforcement decision and imposed fines totalling €146m. The breakdown of the fines imposed was: •